4.6 Letter

Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A

Journal

AMERICAN JOURNAL OF HEMATOLOGY
Volume 97, Issue 11, Pages E416-E419

Publisher

WILEY
DOI: 10.1002/ajh.26692

Keywords

-

Categories

Funding

  1. AbbVie
  2. Genentech

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available